Updated 07 August 2026 · HodieLabs Clinical Governance Lead · The HodieLabs Evidence-Based Clinical Library
LDL cholesterol that has been oxidised; directly drives arterial plaque formation. Oxidised LDL (OxLDL) is measured by blood test as part of the Cardiovascular panel in the HodieLabs Health Blueprint.
Use as an adjunct marker; interpret trend over time. Interpret using the reporting lab’s reference interval and clinical context; trend over time is often more informative than a single value.
Associated risks when out of range: Oxidative stress. Atherogenesis (contextual).
The HodieLabs Evidence-Based Clinical Library classifies Oxidised LDL (OxLDL) as an emerging adjunctive evidence-tier biomarker. Its reference ranges come from a published authority standard rather than from observational optimisation targets. The standard used here is Emerging atherosclerosis biomarker evidence (Mercodia assay); oxidised LDL <60 U/L reflects lower atherogenic oxidative stress. Where relevant clinical outcomes are noted on this page, they reflect the guideline literature referenced below.
The HodieLabs Evidence-Based Clinical Library interprets Oxidised LDL (OxLDL) against published clinical authority standards, never arbitrary "optimal" ranges. Measured in U/L (lab dependent):
Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.
Oxidised LDL (OxLDL) is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.
1. Emerging atherosclerosis biomarker evidence (Mercodia assay); oxidised LDL <60 U/L reflects lower atherogenic oxidative stress.
This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.
LDL cholesterol that has been oxidised; directly drives arterial plaque formation.
The HodieLabs Evidence-Based Clinical Library optimal range is <60 U/L (lab dependent), based on Emerging atherosclerosis biomarker evidence (Mercodia assay); oxidised LDL <60 U/L reflects lower atherogenic oxidative stress.
Annual testing is recommended for most adults as part of a comprehensive preventative panel; more often if a result is being actively managed.
Evidence-supported levers include: improve insulin sensitivity, increase exercise, diet quality, stop smoking. Interpretation and an action plan should always involve your doctor.
Oxidised LDL (OxLDL) is measured in the HodieLabs Health Blueprint at our Melbourne Preventative Health and Longevity Clinic at 85 Spring Street, with doctor-led interpretation against evidence-based reference ranges.
Oxidised LDL (OxLDL) and 50+ biomarkers, measured and doctor-interpreted at our Melbourne clinic.